Are bi-specific antibody treatments FDA approved for cancer?

Communities›Multiple Myeloma›Are bi-specific antibody treatments FDA approved for cancer?

OK

Community Member

2 months ago

Any one familiar with bi specific antibody treatments? I heard it was an FDA Approved option

2 comments

Comment

Accepted Answer

Yes, there are FDA-approved bispecific antibody treatments for multiple myeloma! Several have received approval in recent years, including teclistamab and elranatamab, which target both BCMA on myeloma cells and CD3 on T-cells to help the immune system fight the cancer. These treatments represent an exciting advancement in myeloma care and are typically used for patients with relapsed or refractory disease. It's great that you're staying informed about new treatment options - discussing these possibilities with your oncology team can help determine what might be right for your specific situation.

3+ patients found this helpful

MM

Community Member

2 months ago

Yes. TALVEY is one. I'm on it and it worked after a failed CAR T by ABECMA and chemotherapy .

CA

Community Member

2 months ago

Yes, there are FDA-approved bispecific antibody treatments for multiple myeloma! Several have received approval in recent years, including teclistamab and elranatamab, which target both BCMA on myeloma cells and CD3 on T-cells to help the immune system fight the cancer. These treatments represent an exciting advancement in myeloma care and are typically used for patients with relapsed or refractory disease. It's great that you're staying informed about new treatment options - discussing these possibilities with your oncology team can help determine what might be right for your specific situation.

Are bi-specific antibody treatments FDA approved for cancer?

Related Questions